Florida Finance Today
SEE OTHER BRANDS

News on finance and banking in Florida

Florida Finance Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Finance Today.

Press releases published on May 14, 2025

Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Phase 3 LEVEL Enrollment Completion for TNX-103 in PH-HFpEF Targeted Around Year-End 2025, with Topline Data Expected Middle of 2026 Initiation of Second Phase 3 Study, LEVEL-2, Expected This Year CHAPEL HILL, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Tenax …

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

QUELIMMUNE adoption drives four-fold increase in sequential quarter net revenue NEUTRALIZE AKI trial exceeds 50% enrollment, triggers start of Interim Analysis Webcast Today at 4:30 pm Eastern Time DENVER, May 14, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical …

Rekor Systems Reports First Quarter 2025 Financial Results

Rekor Systems Reports First Quarter 2025 Financial Results

Gross Revenue: Quarterly gross revenue of $9.2 million, representing a 6% decrease from $9.8 million in 2024. Improved Adjusted EBITDA: Substantially narrowed Adjusted EBITDA loss from $9.4 million in Q1 2024 to $7.4 million in Q1 2025, underscoring …

Reliance Global Group Reports 2025 First Quarter Results and Provides Business Update

Reliance Global Group Reports 2025 First Quarter Results and Provides Business Update

LAKEWOOD, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today provided a business update and reported financial results for the quarter ended March 31, 2025. “We are pleased to begin …

Codexis Reports First Quarter 2025 Financial Results

Codexis Reports First Quarter 2025 Financial Results

Secured first revenue-generating contract for ECO Synthesis™ manufacturing services Company reiterates full-year financial guidance Six presentations to feature the ECO Synthesis platform at upcoming TIDES USA annual meeting, including three from leading …

Epsilon Reports First Quarter 2025 Results

Epsilon Reports First Quarter 2025 Results

HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2025 financial and operating results. First Quarter 2025 Highlights: Epsilon - Q1 2025               Q1 2025 Q4 2024 Q1 …

eGain Announces Third Quarter 2025 Financial Results

eGain Announces Third Quarter 2025 Financial Results

SUNNYVALE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- eGain (Nasdaq: EGAN), the AI knowledge management platform for service, today announced financial results for its fiscal 2025 third quarter ended March 31, 2025. “Our third quarter results exceeded …

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of …

SKYX Reports Record First Quarter 2025 of $20.1 Million Compared to $18.9 Million for First Quarter 2024 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

SKYX Reports Record First Quarter 2025 of $20.1 Million Compared to $18.9 Million for First Quarter 2024 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

Company expects its products to be in 30,000 U.S. and Canadian homes by the end of the Second quarter of 2025. Company is Progressing with Significant Projects and Orders that will Enable it to Become Cash Flow Positive in Second Half of 2025 General and …

Toro Corp. Announces Full Repayment of the Senior Term Loan Granted to Castor Maritime Inc.

Toro Corp. Announces Full Repayment of the Senior Term Loan Granted to Castor Maritime Inc.

LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Toro Corp. (NASDAQ: TORO) (“Toro”, or the “Company”), an international energy transportation services company, announces that on May 5, 2025, the senior term loan facility granted to Castor Maritime Inc. …

Snail, Inc. Reports First Quarter 2025 Financial Results

Snail, Inc. Reports First Quarter 2025 Financial Results

CULVER CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) --  Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced financial results for its first …

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for sNDA submission in Q3 2025; designed to reduce treatment …

TMC Provides First Quarter 2025 Corporate Update

TMC Provides First Quarter 2025 Corporate Update

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading explorer of the world’s largest undeveloped resource of critical metals essential to energy, defense, manufacturing, and infrastructure …

Galapagos kondigt mondelinge presentaties aan tijdens EHA en ICML 2025 met veelbelovende nieuwe resultaten uit de ATALANTA-1 studie met CAR-T kandidaat GLPG5101

Galapagos kondigt mondelinge presentaties aan tijdens EHA en ICML 2025 met veelbelovende nieuwe resultaten uit de ATALANTA-1 studie met CAR-T kandidaat GLPG5101

Mechelen, België; 14 mei 2025, 22:01 CET; Galapagos NV (Euronext …

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext …

Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights

Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights

Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded to include primary membranous nephropathy cohort …

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee …

Usio Announces First Quarter 2025 Financial Results

Usio Announces First Quarter 2025 Financial Results

Record First Quarter Revenues of $22.0 million Total payment dollars processed through all payment channels up 34% versus the prior year period  SAN ANTONIO, May 14, 2025 (GLOBE NEWSWIRE) -- Usio, Inc. (Nasdaq: USIO), a leading FinTech company that …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service